OS Therapies IncorporatedOSTXNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P0
Near historical low
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2024-11.83%
2023-2.26%
202251.39%
2021361193.14%
20200.00%